These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7490440)

  • 1. Fluoroquinolones.
    Hendershot EF
    Infect Dis Clin North Am; 1995 Sep; 9(3):715-30. PubMed ID: 7490440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symposium on antimicrobial therapy. VII. The fluoroquinolones.
    Greenfield RA
    J Okla State Med Assoc; 1993 Apr; 86(4):166-74. PubMed ID: 8387106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging resistance problems among respiratory tract pathogens.
    Lister PD
    Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone antibiotics: properties of the class and individual agents.
    Stratton C
    Clin Ther; 1992; 14(3):348-75; discussion 347. PubMed ID: 1638577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic decisions: assessing clinical fit.
    Barriere SL
    Pharmacotherapy; 1993; 13(2 Pt 2):18S-22S. PubMed ID: 8474933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
    Fong IW
    Clin Invest Med; 1989 Feb; 12(1):44-9. PubMed ID: 2646054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing considerations in fluoroquinolone therapy.
    Gentry LO
    Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolones: a comprehensive review.
    Oliphant CM; Green GM
    Am Fam Physician; 2002 Feb; 65(3):455-64. PubMed ID: 11858629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis].
    Niederman MS
    Medicina (B Aires); 1999; 59 Suppl 1():23-30. PubMed ID: 10436551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quinolones: decades of development and use.
    Emmerson AM; Jones AM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary tract infections: risk factors and therapeutic trends].
    Margariti PA; Astorri AL; Mastromarino C
    Recenti Prog Med; 1997 Feb; 88(2):65-8. PubMed ID: 9148368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.